AML cell lines cultured with this serum replacement (insulin-transferrin-selenium+linoleic acid, ITS+1) showed viability and apoptosis rates comparable to conventional fetal bovine serum (FBS)-supplemented cultures. Here, TF is linked to acute myeloid leukemia.